Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOMARIN PHARMACEUTICAL INC Director's Dealing 2012

May 10, 2012

30583_dirs_2012-05-10_59e5153c-9fa0-49ae-9b95-d68344efa62b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-04-30

Reporting Person: BAFFI ROBERT (EVP, Technical Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-04-30 Common Stock A 920 $19.346 Acquired 84413 Direct
2012-05-08 Common Stock A 16000 Disposed 100413 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-05-08 Stock Option (right to buy) $37.46 A 40000 Acquired 2022-05-07 Common Stock (40000) Direct

Footnotes

F1: The reporting person is voluntarily reporting the acquisition of shares of the issuer's Employee Stock Purchase Program ("ESPP"), for the ESPP purchase period of November 1, 2011 to April 30, 2012.

F2: Restricted stock units granted May 8, 2012. Price not applicable.

F3: Options vest on November 8, 2012 and 1/48th on the 8th of each month thereafter.